Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Pankaj Vats
Affiliation
Michigan Center for Translational Pathology, University of Michigan ann arbor
ORCID
Career Start Year
2008
Papers
61
H Index
26
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37267699
Genomics driven precision oncology in advanced biliary tract cancer improves survival.
Neoplasia
2023
37275084
A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.
Indian J Otolaryngol Head Neck Surg
2023
37267699
Genomics driven precision oncology in advanced biliary tract cancer improves survival.
Neoplasia
2023
37425208
A case of dermatofibrosarcoma protuberans of the scalp treated with surface mould brachytherapy.
J Contemp Brachytherapy
2023
37425208
A case of dermatofibrosarcoma protuberans of the scalp treated with surface mould brachytherapy.
J Contemp Brachytherapy
2023
37275084
A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.
Indian J Otolaryngol Head Neck Surg
2023
35945154
A GPU-accelerated compute framework for pathogen genomic variant identification to aid genomic epidemiology of infectious disease: a malaria case study.
Brief Bioinform
2022
35945154
A GPU-accelerated compute framework for pathogen genomic variant identification to aid genomic epidemiology of infectious disease: a malaria case study.
Brief Bioinform
2022
36054329
de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project.
Hum Mutat
2022
36054329
de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project.
Hum Mutat
2022
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
33630025
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
JAMA Oncol
2021
34099557
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Proc Natl Acad Sci U S A
2021
33762485
Advances in radiotherapy in 2020: Hypofractionation - less is more in times of COVID-19.
Indian J Cancer
2021
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
33630025
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
JAMA Oncol
2021
33762485
Advances in radiotherapy in 2020: Hypofractionation - less is more in times of COVID-19.
Indian J Cancer
2021
34099557
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Proc Natl Acad Sci U S A
2021
32299640
Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Eur Urol
2020
31728962
Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.
Methods Mol Biol
2020
32299640
Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Eur Urol
2020
32114502
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer.
J Immunother Cancer
2020
32154134
Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.
Transl Pediatr
2020
31983310
Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing Adenoma.
Hypertension
2020
33033789
Identification of Somatic Mutations in <i>CLCN2</i> in Aldosterone-Producing Adenomas.
J Endocr Soc
2020
32628669
GSMN-ML- a genome scale metabolic network reconstruction of the obligate human pathogen Mycobacterium leprae.
PLoS Negl Trop Dis
2020
32499547
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
Nat Commun
2020
31728962
Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.
Methods Mol Biol
2020
31983310
Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing Adenoma.
Hypertension
2020
33033789
Identification of Somatic Mutations in <i>CLCN2</i> in Aldosterone-Producing Adenomas.
J Endocr Soc
2020
32628669
GSMN-ML- a genome scale metabolic network reconstruction of the obligate human pathogen Mycobacterium leprae.
PLoS Negl Trop Dis
2020
32154134
Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.
Transl Pediatr
2020
32114502
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer.
J Immunother Cancer
2020
32499547
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
Nat Commun
2020
30709876
Refractory and metastatic infantile fibrosarcoma harboring <i>LMNA-NTRK1</i> fusion shows complete and durable response to crizotinib.
Cold Spring Harb Mol Case Stud
2019
31741959
Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients.
Indian J Otolaryngol Head Neck Surg
2019
31243372
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Nature
2019
30709876
Refractory and metastatic infantile fibrosarcoma harboring <i>LMNA-NTRK1</i> fusion shows complete and durable response to crizotinib.
Cold Spring Harb Mol Case Stud
2019
31741959
Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients.
Indian J Otolaryngol Head Neck Surg
2019
31243372
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Nature
2019
29302777
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.
Acta Neuropathol
2018
32832831
Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.
JCO Precis Oncol
2018
32832832
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.
JCO Precis Oncol
2018
30049282
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Acta Neuropathol Commun
2018
30285995
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
Am J Surg Pathol
2018
29906450
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Cell
2018
29941307
Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma.
Eur Urol
2018
29572239
Identification of novel <i>MECOM</i> gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.
Cold Spring Harb Mol Case Stud
2018
29302777
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.
Acta Neuropathol
2018
29337305
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
J Clin Invest
2018
1 - 50 of 122
Column Actions
Search
Recommended Authors
Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Career Start Year
2013
Number of shared co-authors
1
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year
2012
Number of shared co-authors
0
Dylan Nelson
Oregon State University
Career Start Year
2011
Number of shared co-authors
0
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2010
Number of shared co-authors
2
Austin K Mattox
Howard Hughes Medical Institute
Career Start Year
2009
Number of shared co-authors
2
Farhoud Faraji
University of California San Diego Health
Career Start Year
2008
Number of shared co-authors
0
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
8
Malak Abedalthagafi
Emory School of Medicine
Career Start Year
2008
Number of shared co-authors
4
Julien Masliah-Planchon
Curie Institute Hospital Group
Career Start Year
2008
Number of shared co-authors
2
Xinmin Li
University of California los angeles
Career Start Year
2008
Number of shared co-authors
0
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
7
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
1
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year
2005
Number of shared co-authors
1
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
4
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
13
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
7
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
8
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
4
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year
2001
Number of shared co-authors
1
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
11
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
11
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year
1999
Number of shared co-authors
11
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year
1998
Number of shared co-authors
0
Samuel L Volchenboum
University of Chicago
Career Start Year
1998
Number of shared co-authors
2
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
5
Nam Bui
Stanford University
Career Start Year
1996
Number of shared co-authors
0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
13
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
7
row(s) 1 - 30 of 30
Collaborators
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers
32
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers
23
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers
19
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers
19
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers
16
Chandan Kumar-Sinha
Co-authored papers
14
Marcin Cieslik
Co-authored papers
11
Saravana M Dhanasekaran
Co-authored papers
10
Rajen Mody
Co-authored papers
10
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers
10
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers
10
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers
9
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers
7
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers
5
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers
5
Thomas J Giordano
University of Michigan ann arbor
Co-authored papers
4
Lili Zhao
Co-authored papers
4
Katayoon Kasaian
Ontario Institute for Cancer Research
Co-authored papers
4
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers
4
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers
4
Carl Koschmann
University of Michigan-Ann Arbor
Co-authored papers
4
Sriram Venneti
Co-authored papers
4
David C Smith
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Co-authored papers
4
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Co-authored papers
3
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Maha Hussain
Northwestern University
Co-authored papers
3
Johann S de Bono
The Institute for Cancer Research
Co-authored papers
3
Elena M Stoffel
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers
3
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers
3
Christine Brennan
University of Michigan ann arbor
Co-authored papers
3
1 - 30